Menu Search

Switzerland

SPI Large Company IndexLast 5 days
Last price20,392.05
SPI Medium Company IndexLast 5 days
Last price26,520.23
SPI Small Company IndexLast 5 days
Last price33,470.78
Swiss All-Share IndexLast 5 days
Last price907.90
SMILast 5 days
Last price14,756.86

Loading...

CHF overview

PairLatest rateToday's change1 year change
CHFGBP0.9066
GBP		-0.0001 / -0.02%-0.0414 / -4.37%
Today
0.8997Oct 01 20260.9713Mar 02 2026
CHFEUR1.09
EUR		0.0012 / 0.12%0.008 / 0.74%
Today
1.05Sep 30 20261.11Mar 09 2026
CHFUSD1.22
USD		0.0025 / 0.21%-0.0315 / -2.52%
Today
1.19Oct 14 20261.31Jan 27 2026
CHFJPY191.52
JPY		0.22 / 0.12%-0.665 / -0.35%
Today
187.46Sep 30 2026204.42Apr 21 2026
CHFAUD1.73
AUD		0.0025 / 0.14%-0.1744 / -9.17%
Today
1.70Sep 18 20261.95Nov 18 2025
CHFCAD1.70
CAD		-0.0001 / -0.01%-0.047 / -2.69%
Today
1.69Oct 29 20261.79Jan 27 2026
CHFCNY8.09
CNY		0.0121 / 0.15%-0.7744 / -8.73%
Today
7.97Oct 14 20269.14Jan 27 2026

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of Switzerland in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of May 19 2021.

Market movers

Constituents of the SMI with the highest percent gain over one day.
ListingLastChangeVolume
Highlight Event and Entertainment AGHLEE:SWX5.00
CHF		+0.48
+10.62%		260.00
Feintool International Holding AGFTON:SWX11.50
CHF		+0.70
+6.48%		3.99k
Lastminute.com NVLMN:SWX9.82
CHF		+0.44
+4.69%		34.99k
Sandoz Group AGSDZ:SWX83.38
CHF		+3.50
+4.38%		2.10m
Santhera Pharmaceuticals Holding AGSANN:SWX15.60
CHF		+0.64
+4.28%		249.14k
Centiel AGCNTL:SWX5.92
CHF		+0.22
+3.86%		191.86k
Tecan Group AGTECN:SWX255.20
CHF		+8.40
+3.40%		159.10k
Newron Pharmaceuticals SpANWRN:SWX9.13
CHF		+0.29
+3.28%		62.21k
Amrize AGAMRZ:SWX34.14
CHF		+1.05
+3.17%		4.15m
Wiseqey CorpWQEY:SWX7.47
CHF		+0.227
+3.13%		7.52k
Data delayed at least 15 minutes, as of Oct 29 2026 16:01 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.